Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Bicalutamide With or Without Everolimus in Treating Patients With Recurrent or Metastatic Prostate Cancer (UCDCC#215)

This study has been completed.
Information provided by (Responsible Party):
University of California, Davis Identifier:
First received: December 24, 2008
Last updated: January 7, 2016
Last verified: January 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2016
  Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)